Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-12
DOI
10.1038/s41598-020-73218-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare Databases: Use in Clinical Research for Improving Colorectal Cancer Outcomes
- (2019) Meghan Daly et al. Clinics in Colon and Rectal Surgery
- Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
- (2019) Beatriz García-Pinel et al. Nanomaterials
- Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
- (2019) Xin-Yu Wang et al. World Journal of Gastrointestinal Oncology
- Early‐onset colorectal cancer: What reported statistics can and cannot tell us and their implications
- (2019) Chyke A. Doubeni CANCER
- Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
- (2018) S Siena et al. ANNALS OF ONCOLOGY
- An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma
- (2018) Kelly Zatta et al. Nanomaterials
- The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients
- (2017) Riyad Bendardaf et al. Libyan Journal of Medicine
- P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting
- (2017) Prashanth Gokare et al. Scientific Reports
- Preparation and investigation of solid lipid nanoparticles for drug delivery
- (2016) Gokce Dicle Kalaycioglu et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Insight to drug delivery aspects for colorectal cancer
- (2016) Arvind Gulbake WORLD JOURNAL OF GASTROENTEROLOGY
- Growth of Human Colon Cancer Cells in Nude Mice is Delayed by Ketogenic Diet With or Without Omega-3 Fatty Acids and Medium-chain Triglycerides
- (2015) Guang-Wei Hao et al. Asian Pacific Journal of Cancer Prevention
- Mouse models of colorectal cancer as preclinical models
- (2015) Rebecca E. McIntyre et al. BIOESSAYS
- MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells
- (2015) Honghe Zhang et al. CANCER LETTERS
- The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
- (2015) Steven N. Steinway et al. PLoS One
- Characterization and Evaluation of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles Prepared via a Temperature-Modulated Solidification Technique
- (2014) Meghavi N. Patel et al. AAPS PHARMSCITECH
- A new model of time scheme for progression of colorectal cancer
- (2014) Shuhao Sun et al. BMC Systems Biology
- Dual drug delivery of 5-fluorouracil (5-FU) and methotrexate (MTX) through random copolymeric nanomicelles of PLGA and polyethylenimine demonstrating enhanced cell uptake and cytotoxicity
- (2014) N. Ashwanikumar et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
- (2014) Ailian Xiong et al. Cancers
- Evaluation of the growth pattern of carcinoma of colon and rectum by MDCT
- (2013) Seung Joon Choi et al. ACTA RADIOLOGICA
- Mathematical modeling of drug dissolution
- (2013) J. Siepmann et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- High melting lipid based approach for drug delivery: Solid lipid nanoparticles
- (2013) Sacheen Kumar et al. Materials Science & Engineering C-Materials for Biological Applications
- Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil
- (2013) Jennifer I. Hare et al. PLoS One
- MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors
- (2012) A. B. Turke et al. CANCER RESEARCH
- Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats
- (2012) Hassan I El-Sayyad et al. International Journal of Biological Sciences
- EGFR and HER2 inhibition in pancreatic cancer
- (2012) Naomi Walsh et al. INVESTIGATIONAL NEW DRUGS
- Higuchi equation: Derivation, applications, use and misuse
- (2011) Juergen Siepmann et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- USING ULTRAFILTRATION TO FACILITATE SIMULTANEOUS QUANTIFICATION OF 5-FLUOROURACIL IN MOUSE PLASMA AND TISSUES BY HPLC
- (2011) Ning Wang et al. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
- Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
- (2010) Ymera Pignochino et al. BMC CANCER
- The size of solid lipid nanoparticles: An interpretation from experimental design
- (2010) Carla Vitorino et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Preparation and passive target of 5-fluorouracil solid lipid nanoparticles
- (2010) Bin Du et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Optimization of immunoprecipitation–western blot analysis in detecting GW182-associated components of GW/P bodies
- (2009) Joanna J Moser et al. Nature Protocols
- EGFR and HER2 expression in advanced biliary tract cancer
- (2009) Jan Harder et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
- (2008) Su Li et al. BMC CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started